The Latest Cancer Agents and Their Complications
- PMID: 30037436
- DOI: 10.1016/j.emc.2018.04.006
The Latest Cancer Agents and Their Complications
Abstract
The latest cancer agents, collectively known as cancer immunotherapy, have tremendously increased the armamentarium against cancer. Their targeted mechanisms seem ideal, but they do come with complications. As these therapies become more widespread, emergency physicians everywhere must be aware of the immune-related adverse events that can occur, and be ready to identify and coordinate treatment. This article provides the emergency physician with a brief introduction and overview of immunotherapy drugs and their complications.
Keywords: Adoptive immunotherapy; CAR-T; Cancer; Cancer vaccines; Checkpoint modulators; Immune-related adverse events; Immunotherapy; Oncologic emergency.
Copyright © 2018 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
